ClearPoint Neuro posts Q3 2026 revenue of $12.1 million, raises full-year outlook
The company said neurosurgery navigation and therapy revenue grew 59% on IRRAflow sales, and it raised 2026 revenue guidance to $48.0 million to $50.0 million.
SEC filing